Hemochromatosis, type 4: Clinical Trials

1 trial for Hemochromatosis, type 4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Hemochromatosis, type 4: new trials by email Literature Review of Hemochromatosis, type 4 trials Research Report on Hemochromatosis, type 4

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
iron fumarate - Hemochromatosis, Type 4, Ferroportin Disease
Phase 2CompletedRennes University Hospital622014-02-102019-03-27

Narrower conditions

Disease (1)  ·  Hemochromatosis (1)  ·  Hyperferritinemia (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Iron Metabolism Disorders (1)  ·  Iron Overload (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Metal Metabolism, Inborn Errors (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Rennes University Hospital (1)

Countries

France (1)